In 2025, the revenues from oncology drugs in the United States totaled approximately billion U.S. dollars. Immunosuppressants followed with a revenue of about billion U.S. dollars.
High demand for drugs to treat high blood pressure
In the United States, the therapeutic class with the most prescriptions was antihypertensives, which are effective in lowering blood pressure. Sales of antihypertensives generated around billion U.S. dollars in 2023, representing just around percent of the total amount of money spent on medicines in the United States during the year.
Counting the cost of diabetes
The number of prescriptions dispensed for the use of anti-diabetes drugs stood at million in 2022; spending on anti-diabetic medicines increased over the last years. One reason for this could be a rise in the price of diabetes medications. When drug manufacturers own the patent to certain medicines, they can sell the product at a higher price because there is a lack of competition in the market. Prices start to fall when this market exclusivity ends, and generic versions enter the market.